Search Results 811-820 of 18209 for Immunode

1. (QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive - Mayo Clinic

   Known infection with human immunodeficiency virus, or active hepatitis B or C, or other active clinically relevant liver disease. Unwillingness to receive ...

2. A Study of MPDL3280A in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer - Mayo Clinic

   Positive test for human immunodeficiency virus (HIV) and/or active hepatitis B or hepatitis C or tuberculosis; Severe infections within 4 weeks prior to ...

3. A Study to Evaluate Safety of Enapotamab Vedotin in Patients with Solid Tumors - Mayo Clinic

   Known human immunodeficiency virus seropositivity. Known history / positive serology for hepatitis B (unless immune due to vaccination or resolved natural ...

4. A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy - Mayo Clinic

   Known Human Immunodeficiency Virus (HIV), active Hepatitis B Virus (HBV), and/or active Hepatitis C Virus (HCV) infection. Prior therapy with lenalidomide ...

5. Selinexor, Carfilzomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Known to be human immunodeficiency virus (HIV) seropositive; Known active hepatitis A, B, or C infection; or known to be positive for hepatitis C virus (HCV) ...

6. A Study to Evaluate the Addition of Immunotherapy into Adjuvant Therapy for Non-small Cell Lung Cancer - Mayo Clinic

   Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months are eligible for this ...

7. A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03) - Mayo Clinic

   Subjects may be tested for human immunodeficiency virus (HIV) prior to ... immunodeficiency syndrome-defining opportunistic infection within the past ...

8. A Study to investigate efficacy and safety of teplizumab compared with placebo in participants 1 to 25 years of age with Stage 3 Type 1 Diabetes - Mayo Clinic

   At screening, participant has positive serology for human immunodeficiency virus (HIV), hepatitis B (HBV), or hepatitis C (HCV). Participant has evidence of ...

9. SGI-110 in Adults With Untreated Acute Myeloid Leukemia (AML), Not Considered Candidates for Intensive Remission Induction - Mayo Clinic

   Known active human immunodeficiency virus (HIV), hepatitis B virus (HBV), or hepatitis C virus (HCV) infection. Inactive hepatitis carrier status or low ...

10. Ixazomib Plus Pomalidomide and Dexamethasone in Treating Patients with Relapsed or Relapsed/Refractory Multiple Myeloma - Mayo Clinic

    Ongoing or active systemic infection, active hepatitis B or C virus infection, or known human immunodeficiency virus (HIV) positive; Any serious medical or ...